Bile Duct Cancer

About Bile Duct Cancer

Bile duct cancer, also known as cholangiocarcinoma, is a rare and aggressive cancer that begins in the bile ducts, which are small tubes that carry bile from the liver to the gallbladder and small intestine. The bile ducts are essential for digestion, as bile helps break down fats. Bile duct cancer can occur in the intrahepatic bile ducts (inside the liver), the extrahepatic bile ducts (outside the liver), or the periampullary area (where the bile duct meets the pancreas).

This cancer often develops slowly and may not show symptoms until it is in an advanced stage, making early detection challenging. At Apex, we utilize advanced imaging techniques and diagnostic tools to detect bile duct cancer early, offering specialized care and treatment to enhance patient outcomes.

Symptoms of Bile Duct Cancer

Common symptoms of bile duct cancer include:

Jaundice (yellowing of the skin or eyes).
Abdominal pain, especially in the upper right side of the abdomen.
Unexplained weight loss.
Fever and chills.
Dark-colored urine and pale stools.
Itchy skin (pruritus).
Loss of appetite and nausea.

Note: In its early stages, bile duct cancer may not present noticeable symptoms. Regular checkups and screenings, particularly for individuals at high risk, are important for early detection.

Causes of Bile Duct Cancer

Several factors increase the risk of developing bile duct cancer, including:

Primary Sclerosing Cholangitis (PSC): A chronic condition causing inflammation and scarring of the bile ducts, which can lead to bile duct cancer.
Liver Disease: Chronic liver conditions such as cirrhosis or hepatitis B and C increase the risk.
Bile Duct Inflammation: Chronic infection or inflammation of the bile ducts can trigger cancer development.
Age: The risk of bile duct cancer increases with age, typically affecting individuals over 50.
Tobacco Use: Smoking increases the risk of developing bile duct cancer.
Genetic Conditions: Certain genetic conditions like Caroli’s disease or cystic fibrosis can increase the likelihood of developing bile duct cancer.

Exposure to Chemicals: Long-term exposure to certain chemicals, such as those used in the petroleum or rubber industries, has been linked to a higher risk of bile duct cancer.

Reducing Your Risk

Maintain a healthy weight and avoid smoking.
Manage chronic liver conditions like hepatitis or cirrhosis with medical care.
If you have a family history of bile duct cancer or related conditions, consider genetic counseling and testing.
Avoid exposure to harmful chemicals, especially in high-risk industries.
Regular checkups for individuals with primary sclerosing cholangitis or other liver diseases can help detect early signs of bile duct cancer.

Take Action

If you are experiencing symptoms or have risk factors for bile duct cancer, schedule a consultation with our expert oncology team at Apex. Early detection is essential to improving outcomes, and we offer advanced diagnostic tools, treatment options, and compassionate care tailored to your individual needs. Reach out to us today for more information and to schedule an appointment.

Emergency Cases

+91 89280 08099

If you suspect cancer or are currently managing it and face a medical emergency, please call us for guidance on how to handle the situation.

Enquire Now

+91 89280 08099

Have a question?
Call us now.

contact@apexoncocare.com

Need support?
Drop us an email.

Address

3rd Floor, 301 Meraki Arena, Above Croma Store, Sion -Trombay Road, Opp. Godrej RKS, Chembur, Mumbai Pincode - 400 071.

Dr. Amit M. Gupta

Dr Amit M. Gupta (“Maharashtra Ratna”, 2022) is amongst a select few in the country with Post Doctoral Certified Fellowship in Gastrointestinal HPB (Liver, Gallbladder, Pancreas, Stomach) and Retroperitoneal Oncosurgery. He did his post-doctoral from the very prestigious Tata Memorial Hospital. He learned Gastrointestinal HPB and Retroperitoneal Oncosurgery from the well-reckoned Dr. (Prof.) Shailesh Vinayak Shrikhande and Dr. (Prof.) Mahesh Goel.

QUICK LINKS

SERVICES

Handkrafted with ♥ by Social DNA.